Home
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
中国 — 简体中文
Global — English
Home
Technology Platforms
BACK
Technology Platforms
Harbour Mice
®
Single Cell Technology Platform
HBICE
®
Fully Human Generative AI HCAb Model
Therapeutics
BACK
Therapeutics
Inflammatory & Immunology Diseases
Oncology/Immuno-Oncology
Weight Management
Publications
Harbour Medical
BACK
Harbour Medical
Overview
Clinical Development & Medical Services
Scientific Committee
IND-IIT Bidirectional Drive Model
AI-Empowered Full Clinical Trial Lifecycle
An Efficient and Collaborative Organizational System
Partnership
BACK
Partnership
Technology Service
Technology License
Asset License
Co-development
Strategic Collaboration
Cooperation Contact
About Us
BACK
About Us
Company Overview
Corporate Strategy
Management Team
Scientific Advisory Board
Our History
Our Locations
Newsroom
Investor Relations
BACK
Investor Relations
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Careers
Investor Relations
Effective Communication Drives Development
Corporate Governance
Stock Information
Disclosure
Financials
Presentations and Events
Analyst Coverage
Notices-Replacement of Lost Share Certificates
Subscribe to Updates
Home
>
Investor Relations
>
Disclosure
Disclosure
Listing Documents
Financial Report/ESG information
Announcement & Notice
IR Journal
2025-04-10
VOLUNTARY ANNOUNCEMENT -ON-MARKET SHARE REPURCHASE
2025-04-08
Next Day Disclosure Return
2025-04-08
COMPLETION OF ISSUE OF SUBSCRIPTION SHARES UNDER GENERAL MANDATE
2025-04-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
2025-04-01
Next Day Disclosure Return
2025-03-31
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
2025-03-21
INSIDE INFORMATION - ISSUE OF SUBSCRIPTION SHARES UNDER GENERAL MANDATE AND COLLABORATION WITH ASTRAZENECA
2025-03-10
DATE OF BOARD MEETING
2025-03-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
2025-03-06
VOLUNTARY ANNOUNCEMENT - UPFRONT PAYMENT RECEIVED UNDER THE LICENSE AGREEMENT WITH WINDWARD BIO AG FOR HBM9378/SKB378
2025-02-26
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATES ON LICENSE AND COLLABORATION FOR HBM9013/HAT001
2025-02-14
Next Day Disclosure Return
2025-02-14
VOLUNTARY ANNOUNCEMENT - BUSINESS PROGRESS AND UPDATE
2025-02-13
Next Day Disclosure Return
2025-02-12
Next Day Disclosure Return
2025-02-11
Next Day Disclosure Return
2025-02-10
Next Day Disclosure Return
2025-02-10
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PROGRESS AND BUSINESS UPDATES
2025-02-07
Next Day Disclosure Return
2025-02-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
1
···
7
8
···
21
Jump